The U.S. Food and Drug Administration (FDA) has announced a new initiative to help provide patients with new and innovative medical technologies that can be used in home settings.
According to the FDA, the new initiative, titled “READI-Home: Reducing Readmissions through Device Innovation for the Home,” invites medical device companies and developers to participate in an innovation challenge, in which they provide proposed solutions for medical device technologies to be used in the home setting.
Applicants will be reviewed by the agency during the Selection Phase, with a limited number selected to proceed to the Interaction Phase. During the Interaction Phase, selected participants will benefit from early engagement with FDA regulatory officials and receive regular feedback so that they can further refine their designs.
The READI-Home initiative is part of the FDA’s Center for Device and Radiological Health’s (CDRH) “Home as a Healthcare Hub Initiative.”
More information about the FDA’s READI-Home Innovation Challenge is available at https://www.fda.gov/medical-devices/home-health-care-hub/fda-readi-home-innovation-challenge-reducing-readmissions-through-device-innovation-home?utm_medium=email&utm_source=govdelivery. The deadline for submitting proposals for the READI-Home initiative’s Selection Phase is September 30, 2026.
